Clinigen Group PLC (LON:CLIN) insider John Bacon sold 200,000 shares of the stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of GBX 843 ($10.98), for a total transaction of £1,686,000 ($2,196,456.49).
Shares of Clinigen Group PLC (LON:CLIN) opened at 991.50 on Friday. The firm has a 50-day moving average of GBX 904.76 and a 200 day moving average of GBX 848.69. Clinigen Group PLC has a one year low of GBX 610.50 and a one year high of GBX 1,000.00. The stock’s market capitalization is GBX 1.14 billion.
ILLEGAL ACTIVITY NOTICE: This piece was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.chaffeybreeze.com/2017/07/29/clinigen-group-plc-clin-insider-john-bacon-sells-200000-shares-of-stock-updated-updated-updated.html.
Several brokerages have commented on CLIN. Numis Securities Ltd lowered shares of Clinigen Group PLC to an “add” rating and set a GBX 1,100 ($14.33) price objective for the company. in a report on Tuesday, July 18th. Stifel Nicolaus restated a “buy” rating and issued a GBX 970 ($12.64) price objective on shares of Clinigen Group PLC in a report on Monday, May 22nd. Peel Hunt restated a “buy” rating on shares of Clinigen Group PLC in a report on Tuesday, April 25th. Finally, N+1 Singer restated a “buy” rating and issued a GBX 895 ($11.66) price objective on shares of Clinigen Group PLC in a report on Thursday, April 13th.
About Clinigen Group PLC
Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.